Eurobio Scientific SA Capital Reinvestment Ratio
Eurobio Scientific SA capital reinvestment ratio. Eurobio Scientific SA (ALERS) has a Capital Reinvestment Ratio of 0.28x as of June 2025, meaning it reinvests 0% of its operating cash flow (€5.36 Million) in capital expenditures (€1.50 Million). Check cash flow reinvestment rate of Eurobio Scientific SA to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Eurobio Scientific SA (2017–2024)
Capital reinvestment ratio of Eurobio Scientific SA from 2017 to 2024. This chart tracks Eurobio Scientific SA's Capital Reinvestment Ratio across 7 annual periods. Also explore ALERS net assets growth trend to track the company's year-over-year net asset growth rate.
Eurobio Scientific SA Capital Reinvestment Ratio by Year (2017–2024)
Eurobio Scientific SA capital reinvestment ratio by year from 2017 to 2024. For the full cash flow conversion analysis, see ALERS cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | €16.70 Million | €3.26 Million | ▲ +28.7% |
| 2023 | 0.15x | €26.77 Million | €4.05 Million | ▲ +130.2% |
| 2022 | 0.07x | €43.07 Million | €2.83 Million | ▲ +134.8% |
| 2021 | 0.03x | €65.92 Million | €1.85 Million | ▼ -33.0% |
| 2020 | 0.04x | €54.93 Million | €2.30 Million | ▼ -86.9% |
| 2019 | 0.32x | €4.99 Million | €1.59 Million | ▼ -79.8% |
| 2017 | 1.58x | €2.48 Million | €3.91 Million | — |